Inventor · disambiguated record
Fangxian Sun
Also filed as: SUN FANGXIAN
3 granted patents·4 pending applications·8 citations·filing 2012–2022
57Inventor score
Top patents by PatentIndex Score
7 records- 0188US11260057B2Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7] annulene-2-carboxylic acid and its use for the treatment of cancerSANOFI SA·Filed 2018·Granted Mar 1, 2022·8 cites·11 claims
- 0260US2022362248A1Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7] annulene-2-carboxylic acid and its use for the treatment of cancerSANOFI SA·Filed 2022·Application pending·0 cites
- 0357US12427142B2Combination comprising alpelisib and 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl[oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acidSANOFI SA·Filed 2021·Granted Sep 30, 2025·0 cites·19 claims
- 0455US2024197692A1Combination Comprising Everolimus and AmcenestrantSANOFI SA·Filed 2022·Application pending·0 cites
- 0555US2024197739A1Combination Comprising Ribociclib and AmcenestrantSANOFI SA·Filed 2022·Application pending·0 cites
- 0655US2023404971A1Combination Comprising Abemaciclib and 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylic AcidSANOFI SA·Filed 2021·Application pending·0 cites
- 0724US8703787B2Methods of using ALK inhibitorsLI NANXIN·Filed 2012·Granted Apr 22, 2014·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →